Expression of the TSC2 product tuberin and its target Rap1 in normal human tissues

American Journal of Pathology

Volumn 150, Issue 1, 1997, Pages 43-50

  Wienecke, Ralf ^a   Maize Jr , John C ^a   Reed, Jon A ^b   De Gunzburg, Jean ^c   Yeung, Raymond S ^d   DeClue, Jeffrey E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

^c INSTITUT CURIE   (France)

^d FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; POLYCLONAL ANTIBODY; POLYPEPTIDE; RAP1 PROTEIN; TUBERIN; UNCLASSIFIED DRUG;

ADRENAL GLAND; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PURKINJE CELL; SKIN; TUBEROUS SCLEROSIS; VASCULAR SMOOTH MUSCLE;

CEREBRAL CORTEX; GENES, TUMOR SUPPRESSOR; GTP-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; MYOCARDIUM; RAP GTP-BINDING PROTEINS; REPRESSOR PROTEINS; SKIN; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0031033220     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Wiederholt WC, Gomez MR, Kurland LT: Incidence and prevalence of tuberous sclerosis in Rochester, Minnesota: 1950 through 1962. Neurology 1985, 35: 600-603
2. Kuntz N: Population studies. Tuberous Sclerosis. Edited by MR Gomez. New York, Raven Press, 1988, pp 213-216
3. Osborne JP, Fryer A, Webb D: Epidemiology of tuberous sclerosis. Ann NY Acad Sci 1991, 615:125-127
4. Northrup H, Wheless JW, Bertin TK, Lewis RA: Variability of expression in tuberous sclerosis. J Med Genet 1993, 30:41-43
5. Rogers RSI: Dermatologic manifestations. Tuberous Sclerosis, Edited by MR Gomez. New York, Raven Press, 1988, pp 75-88
6. Bernstein J, Robbins TO: Renal involvement in tuberous sclerosis. Ann NY Acad Sci 1991, 615:36-49
7. Kwiatkowski DJ, Short MP: Tuberous sclerosis. Arch Dermatol 1994, 130:348-354
8. Shepherd CW, Gomez MR, Lie JT, Crowson CS: Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 1991, 66:792-796
9. European Chromosome 16 Tuberous Slerosis Consortium: Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993, 75:1305-1313
10. Kwiatkowski DJ, Armour J, Bale AE, Fountain JW, Goudie D, Haines JL, Knowles MA, Pilz A, Slaugen-haupt S, Povey S: Report on the second international workshop on human chromosome 9. Cytogenet Cell Genet 1993, 64:94-106
11. Janssen B, Sampson J, van der Est M, Deelen W, Verhoef S, Daniels I, Hesseling A, Brook-Carter P, Nellist M, Lindhout D, Sandkuijl L, Halley D: Redefined localization of TSC1 by combined analysis of 9q34 and 16p34 data in 14 tuberous sclerosis families. Hum Genet 1994, 94:437-440
12. Wienecke R, König A, DeClue JE: Identification of tuberin, the tuberous sclerosis-2 product. J Biol Chem 1995, 270:16409-16414
13. Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MP, Kwiatkowski DJ: Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes & Cancer 1995, 13:295-298
14. Carbonara C, Longa L, Mazzuco G, Borrone C, Garre ML, Brisigotti M, Filippi G, Scabar A, Giannotti A, Falzoni P, Monga G, Garini G, Gabrielli M, Riegler P, Danesino C, Ruggieri M, Magro G, Migone N: Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal region in tuberous sclerosis hamartomas. Genes Chromosomes & Cancer 1996, 15:18-25
15. Jin F, Wienecke R, Xiao G-H, Maize JC, DeClue JE, Yeung RS: Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-termi- nal region. Proc Natl Acad Sci USA 1996, 93:9154-9159
16. Pizon V, Lerosey l, Chardin P, Tavitian A: Nucleotide sequence of a human CDNA encoding a ras-related protein (rap 1B). Nucleic Acids Res 1988, 16:7719-7719
17. Yoshida Y, Kawata M, Miura Y, Musha T, Sasaki T, Kikuchi A, Takai Y: Microinjection of smg/rap1/Krev-1 p21 into Swiss 3T3 cells induces DNA synthesis and morphological changes. Mol Cell Biol 1992, 12:3407-3414
18. Wienecke R, Maize JC, Shoarinejad F, Vass WC, Reed J, Bonifacino JS, Resau JH, de Gunzburg J, Yeung RS, DeClue JE: Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus. Oncogene 1996, 13:913-923
19. Béranger F, Goud B, Tavitian A, de Gunzburg J: Association of the Ras-antagonistic Rap1/Krev-1 proteins with the Golgi complex. Proc Natl Acad Sci USA 1991, 88:1606-1610
20. Corded JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatases and monclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984, 32:219-229
21. Zvulunov A, Esterly NB: Neurocutaneous syndromes associated with pigmentary skin lesions. J Am Acad Dermatol 1995, 32:915-935
22. Zimmerman D: The endocrine system. Tuberous Sclerosis. Edited by MR Gomez. New York, Raven Press, 1988, pp 159-168
23. Lie T: Cardiac, pulmonary, and vascular involvement in tuberous sclerosis. Ann NY Acad Sci 1991, 615:58-70
24. Short MP, Richardson EP, Haines JL, Kwiatkowski DJ: Clinical, neuropathological and genetic aspects of the tuberous sclerosis complex. Brain Pathol 1995, 5:173-179
25. Geist RT, Gutmann DH: The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord. Cell Growth Differ 1995, 6:1477-1483
26. Reagan TJ: Neuropathology. Tuberous Sclerosis. Edited by MR Gomez. New York, Raven Press, 1988, pp 63-74
27. Richardson EP: Pathology of tuberous sclerosis: neuropathologic aspects. Ann NY Acad Sci 1991, 615: 128-139
28. Xiao G-H, Jin F, Yeung RS: Identification of tuberous sclerosis 2 messenger RNA splice variants that are conserved and differentially expressed in rat and human tissues. Cell Growth Differ 1995, 6:1185-1191
29. Xu L, Sterner C, Maheshwar MM, Wilson PJ, Nellist M, Short PM, Haines JL, Sampson JR, Ramesh V: Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues. Genomics 1995, 27:475-480
30. Green AJ, Sepp T, Yates JRW: Clonality of tuberous sclerosis hamartomas shown by non-random X-chromosome inactivation. Hum Genet 1996, 97:240-243
31. Kim H, Kerr A, Morehouse H: The association between tuberous sclerosis and insulinoma. Am J Neuroradiol 1995, 16:1543-1544
32. Watson GH: Cardiac rhabdomyomas in tuberous sclerosis. Ann NY Acad Sci 1991, 615:50-57
33. Ohtsuka T, Shimizu K, Yamamori B, Kuroda S, Takai Y: Activation of brain B-raf protein kinase by Rap 1B small GTP-binding protein. J Biol Chem 1996, 271:1258-1261
34. Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M: A ras-related gene with transformation suppressor activity. Cell 1989, 56:77-84
35. Cook SJ, Rubinfeld B, Albert I, McCormick F: RapV12 antagonizes Ras-dependent activation of ERK1 and ERK2 by LPA and EGF in rat-1 fibroblasts. EMBO J 1993, 12:3475-3485